14-day Premium Trial Subscription Try For FreeTry Free
Date Action Amount Person Type
Apr 01, 2024 Sell 1 330 Yen Kristen Common Stock
Apr 01, 2024 Sell 888 Yen Kristen Common Stock
Apr 01, 2024 Sell 3 104 Mackaness James H Common Stock
Apr 01, 2024 Sell 2 071 Mackaness James H Common Stock
Apr 01, 2024 Sell 888 Hirano Patricia C Common Stock
Apr 01, 2024 Sell 1 330 Hirano Patricia C Common Stock
Apr 01, 2024 Sell 11 383 Anish Bhatnagar Common Stock
Apr 01, 2024 Sell 7 597 Anish Bhatnagar Common Stock
Jan 25, 2024 Sell 397 Yen Kristen Common Stock
Jan 25, 2024 Sell 832 Hirano Patricia C Common Stock
Jan 25, 2024 Sell 2 527 Anish Bhatnagar Common Stock
Jan 08, 2024 Sell 3 523 Mario Ernest Common Stock
Jan 04, 2024 Buy 24 000 Yen Kristen Common Stock
Jan 04, 2024 Buy 16 000 Yen Kristen Employee stock option (right to buy)
Jan 04, 2024 Buy 56 000 Mackaness James H Common Stock
Jan 04, 2024 Buy 37 000 Mackaness James H Employee stock option (right to buy)
Jan 04, 2024 Buy 24 000 Hirano Patricia C Common Stock
Jan 04, 2024 Buy 16 000 Hirano Patricia C Employee stock option (right to buy)
Jan 04, 2024 Buy 150 000 Anish Bhatnagar Common Stock
Jan 04, 2024 Buy 100 000 Anish Bhatnagar Employee stock option (right to buy)
Dec 14, 2023 Sell 1 359 Hirano Patricia C Common Stock
Dec 13, 2023 Sell 4 885 Hirano Patricia C Common Stock
Dec 13, 2023 Buy 4 583 Yen Kristen Common Stock
Dec 13, 2023 Sell 4 583 Yen Kristen Employee stock option (right to buy)
Dec 13, 2023 Buy 13 333 Yen Kristen Common Stock
Dec 13, 2023 Sell 17 916 Yen Kristen Common Stock
Dec 13, 2023 Sell 13 333 Yen Kristen Employee stock option (right to buy)
Dec 12, 2023 Sell 3 629 Yen Kristen Common Stock
Dec 12, 2023 Sell 16 284 Yen Kristen Common Stock
Dec 11, 2023 Sell 51 205 Anish Bhatnagar Common Stock
Dec 11, 2023 Sell 35 272 Anish Bhatnagar Common Stock
Dec 11, 2023 Sell 6 931 Anish Bhatnagar Common Stock
Dec 11, 2023 Buy 15 000 Mackaness James H Common Stock
Dec 11, 2023 Sell 6 252 Mackaness James H Common Stock
Dec 11, 2023 Sell 12 381 Mackaness James H Common Stock
Dec 11, 2023 Sell 13 849 Mackaness James H Common Stock
Dec 11, 2023 Sell 15 000 Mackaness James H Employee stock option (right to buy)
Nov 30, 2023 Sell 8 700 Mario Ernest Common Stock
Nov 30, 2023 Sell 3 963 Yen Kristen Common Stock
Nov 30, 2023 Sell 4 186 Mackaness James H Common Stock
Nov 30, 2023 Sell 3 823 Hirano Patricia C Common Stock
Nov 30, 2023 Sell 27 716 Anish Bhatnagar Common Stock
Nov 29, 2023 Sell 2 047 Yen Kristen Common Stock
Nov 29, 2023 Sell 1 932 Yen Kristen Common Stock
Nov 29, 2023 Sell 2 162 Mackaness James H Common Stock
Nov 29, 2023 Sell 2 041 Mackaness James H Common Stock
Nov 29, 2023 Sell 1 975 Hirano Patricia C Common Stock
Nov 29, 2023 Sell 1 864 Hirano Patricia C Common Stock
Nov 29, 2023 Sell 14 317 Anish Bhatnagar Common Stock
Nov 29, 2023 Sell 13 510 Anish Bhatnagar Common Stock
Nov 28, 2023 Sell 3 034 Yen Kristen Common Stock
Nov 28, 2023 Sell 637 Yen Kristen Common Stock
Nov 28, 2023 Sell 3 205 Mackaness James H Common Stock
Nov 28, 2023 Sell 673 Mackaness James H Common Stock
Nov 28, 2023 Sell 2 927 Hirano Patricia C Common Stock
Nov 28, 2023 Sell 615 Hirano Patricia C Common Stock
Nov 28, 2023 Sell 21 220 Anish Bhatnagar Common Stock
Nov 28, 2023 Sell 4 458 Anish Bhatnagar Common Stock
Oct 20, 2023 Buy 3 500 Anish Bhatnagar Common Stock
Oct 20, 2023 Buy 2 143 Anish Bhatnagar Common Stock
Oct 20, 2023 Buy 4 000 Anish Bhatnagar Common Stock
Oct 20, 2023 Sell 4 000 Anish Bhatnagar Warrants (right to buy)
Oct 20, 2023 Sell 2 143 Anish Bhatnagar Warrants (right to buy)
Oct 20, 2023 Sell 3 500 Anish Bhatnagar Warrants (right to buy)
Oct 02, 2023 Buy 3 500 Mackaness James H Common Stock
Oct 02, 2023 Buy 2 143 Mackaness James H Common Stock
Oct 02, 2023 Buy 2 666 Mackaness James H Common Stock
Oct 02, 2023 Sell 2 666 Mackaness James H Warrants (right to buy)
Oct 02, 2023 Sell 2 143 Mackaness James H Warrants (right to buy)
Oct 02, 2023 Sell 3 500 Mackaness James H Warrants (right to buy)
Oct 02, 2023 Buy 5 215 000 Vivo Opportunity, Llc Common Stock
Oct 02, 2023 Sell 5 215 000 Vivo Opportunity, Llc Tranche B Warrants (right to buy)
Sep 28, 2023 Buy 329 930 Carlyle Group Inc. Common Stock
Sep 28, 2023 Buy 762 126 Carlyle Group Inc. Prefunded Warrants
Sep 28, 2023 Sell 1 092 056 Carlyle Group Inc. Tranche A Warrants
Sep 28, 2023 Buy 250 000 Perceptive Advisors Llc Common Stock
Sep 28, 2023 Buy 250 000 Perceptive Advisors Llc Pre-funded warrants (right to buy)
Sep 26, 2023 Buy 3 203 093 Vivo Opportunity, Llc Common Stock
Sep 26, 2023 Sell 3 203 093 Vivo Opportunity, Llc Tranche A Warrants (right to buy)
Sep 26, 2023 Buy 36 939 Perceptive Advisors Llc Common Stock
Sep 26, 2023 Buy 117 996 Perceptive Advisors Llc Common Stock
Sep 26, 2023 Buy 88 685 Perceptive Advisors Llc Common Stock
Sep 26, 2023 Buy 52 691 Perceptive Advisors Llc Common Stock
Sep 26, 2023 Buy 75 477 Perceptive Advisors Llc Common Stock
Sep 26, 2023 Buy 27 769 Perceptive Advisors Llc Common Stock
Sep 26, 2023 Buy 3 326 Perceptive Advisors Llc Common Stock
Sep 26, 2023 Buy 30 511 Perceptive Advisors Llc Common Stock
Sep 26, 2023 Buy 42 838 Perceptive Advisors Llc Common Stock
Sep 26, 2023 Buy 77 837 Perceptive Advisors Llc Common Stock
Sep 26, 2023 Buy 37 911 Perceptive Advisors Llc Common Stock
Sep 26, 2023 Buy 5 419 Perceptive Advisors Llc Common Stock
Sep 26, 2023 Buy 13 687 Perceptive Advisors Llc Common Stock
Sep 26, 2023 Buy 5 703 Perceptive Advisors Llc Common Stock
Aug 15, 2023 Buy 15 000 Pauls Matthew Stock option (right to buy)
Aug 15, 2023 Buy 0 Pauls Matthew
Jun 06, 2023 Buy 200 Perceptive Advisors Llc Common Stock
Jun 05, 2023 Buy 78 468 Perceptive Advisors Llc Common Stock
Jun 02, 2023 Buy 64 630 Perceptive Advisors Llc Common Stock
May 26, 2023 Buy 10 000 Volck Birgitte Stock option (right to buy)
May 25, 2023 Buy 2 666 Volck Birgitte Stock option (right to buy)
INSIDER POWER
6.221
Last 100 transactions
Buy: 11 271 770 | Sell: 9 891 855 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 6.221.

In total, the insiders bought 11 271 770 and sold 9 891 855 SLNO shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Soleno Therapeutics Inc

Soleno Therapeutics Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing Phase III clinical development program. The company was formerly known as Capnia, Inc. and changed its n... SLNO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT